Item 16. 10-K Summary

2K characters. Original on sec.gov · Markdown

Item 16. 10-K Summary

| --- | --- |

None

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ZIMMER BIOMET HOLDINGS, INC.

	By:	/s/ Bryan C. Hanson
Dated: February 27, 2018		Bryan C. Hanson
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SIGNATURE	TITLE	DATE
/s/ Bryan C. Hanson	President, Chief Executive Officer and Director	February 27, 2018
Bryan C. Hanson	(Principal Executive Officer)

/s/ Daniel P. Florin	Executive Vice President and Chief Financial Officer	February 27, 2018
Daniel P. Florin	(Principal Financial Officer)

/s/ Tony W. Collins	Vice President, Corporate Controller and	February 27, 2018
Tony W. Collins	Chief Accounting Officer
	(Principal Accounting Officer)

/s/ Christopher B. Begley	Director	February 27, 2018
Christopher B. Begley

/s/ Betsy J. Bernard	Director	February 27, 2018
Betsy J. Bernard

/s/ Gail K. Boudreaux	Director	February 27, 2018
Gail K. Boudreaux

	Director
Michael J. Farrell

/s/ Larry C. Glasscock	Director	February 27, 2018
Larry C. Glasscock

/s/ Robert A. Hagemann	Director	February 27, 2018
Robert A. Hagemann

/s/ Arthur J. Higgins	Director	February 27, 2018
Arthur J. Higgins

/s/ Michael W. Michelson	Director	February 27, 2018
Michael W. Michelson

/s/ Cecil B. Pickett, Ph.D.	Director	February 27, 2018
Cecil B. Pickett, Ph.D.

/s/ Jeffrey K. Rhodes	Director	February 27, 2018
Jeffrey K. Rhodes

Previous: Item 15. Exhibits, Financial Statement Schedules